Biosensor as well as preparation method and application thereof

By combining the bilayer corner graphene layer, gold nanoarray layer, DNA origami structure and CRISPR recognition unit in the biosensor, the problem of low detection sensitivity and poor specificity in ultra-low concentration samples in the prior art is solved, and high specificity is achieved and high sensitivity detection capability.

CN119020471AActive Publication Date: 2024-11-26SHENZHEN UNIV

Patent Information

Application Number
CN202411212841.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-26
Estimated Expiration
2044-08-30

AI Technical Summary

Technical Problem

Existing biosensors have low sensitivity and poor specificity in ultra-low concentration samples, making it difficult to achieve high specificity detection.

Method used

The double-layer corner graphene layer and gold nanoarray layer combine DNA origami structure and CRISPR recognition unit to achieve high specificity for SNPs in ultra-low concentration samples through the tetrahedral structure of DNA origami structure and the single-base recognition ability of CRISPR. Test.

Benefits of technology

The photocurrent signal of the biosensor is significantly enhanced, the detection of SNPs in ultra-low concentration samples is realized, the detection capability within the Atmolar range is achieved, and the detection sensitivity and specificity are improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020471A_ABST
    Figure CN119020471A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biosensors, and particularly discloses a biosensor and a preparation method and application thereof.The biosensor comprises a substrate, a DNA origami structure adsorbed to the substrate and a CRISPR recognition unit adsorbed to the DNA origami structure; the substrate comprises a double-layer corner graphene layer and a gold nano array layer which are arranged in a stacked manner, the DNA origami structure is a tetrahedral structure constructed by eight DNA single chains with nucleotide sequences shown as SEQ ID No.1-8 through a DNA origami technology, and the CRIPSR recognition unit is specifically combined with a nucleotide sequence to be detected. According to the biosensor disclosed by the invention, the double-layer corner graphene, the gold nano array, the CRISPR-Cas unit and the DNA origami unit are combined, so that low-abundance nucleic acid targets in a complex biological sample can be recognized, and high-specificity detection on single nucleotide polymorphism in an ultralow-concentration sample is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of biosensors, and in particular to a biosensor and a preparation method and application thereof. Background Art

[0002] Circulating tumor DNA (ctDNA) refers to the DNA of tumor cell somatic cells that is released into the human circulatory system after shedding or apoptosis. It has the characteristics of high sensitivity, high specificity, and short half-life, and is a characteristic tumor biomarker. The main method for detecting single nucleotide polymorphisms (SNPs) in ctDNA is based on polymerase chain reaction (PCR) detection methods, including next-generation sequencing technology (NGS), droplet digital PCR (ddPCR), and amplification of refractory mutation system (ARMS). However, these methods take a long time to process and cannot identify all SNPs.

[0003] As the attention to ctDNA increases, other detection technologies have also been developed, including isothermal amplification, microfluidics, and biosensors. Surface plasmon resonance (SPR) biosensors have the advantages of label-free properties, fast real-time response, and high-throughput testing. However, current SPR biosensors still have many challenges and it is difficult to achieve high-specificity detection of SNPs in ultra-low concentration samples. Therefore, the existing technology needs to be improved. Summary of the invention

[0004] In view of the above-mentioned deficiencies of the prior art, the purpose of the present application is to provide a biosensor and a preparation method and application thereof, aiming to solve the problems of low sensitivity and poor specificity of the prior art in detecting single nucleotide polymorphisms in ultra-low concentration samples.

[0005] The technical solution of this application is as follows:

[0006] In the first aspect of the present application, a biosensor is provided, comprising: a substrate, comprising a stacked double-layer corner graphene layer and a gold nanoarray layer; a DNA origami structure adsorbed on the gold nanoarray layer; a CRISPR recognition unit adsorbed on the DNA origami structure; wherein the DNA origami structure is a tetrahedral structure constructed by DNA origami technology from 8 single DNA strands shown in a nucleic acid sequence such as SEQ ID No.1-8; and the CRISPR recognition unit specifically binds to the nucleic acid sequence to be detected.

[0007] Preferably, the twist angle θ of the two graphene layers in the double-layer twisted graphene layer satisfies 5°≤θ<30°.

[0008] Preferably, the substrate further comprises a substrate layer, wherein the substrate layer comprises a silicon dioxide layer and a silicon layer stacked in sequence, and the silicon dioxide layer is located on a side of the double-layer corner graphene layer away from the gold nanoarray layer.

[0009] The second aspect of the present application provides a method for preparing the biosensor of the first aspect of the present application, comprising the steps of: S1, preparing a substrate; S2, preparing a DNA origami structure; S3, preparing a CRISPR recognition unit; S4, combining the DNA origami structure and the CRISPR recognition unit with the substrate to prepare a biosensor.

[0010] Preferably, the method for preparing the substrate comprises the steps of:

[0011] S11, spin-coating polymethyl methacrylate (PMMA) on a graphene single crystal grown by chemical vapor deposition on a copper foil to obtain a first substrate precursor; S12, cutting the first substrate precursor using a femtosecond laser, and etching the copper foil therein using an etching solution to obtain a second substrate precursor with parallel crystal phases; S13, transferring the second substrate precursor to the center of the silicon dioxide / silicon substrate layer, and removing the polymethyl methacrylate using an acetone solution to obtain a third substrate precursor; S14, transferring the second substrate precursor to the attached polydioxide / silicon substrate layer; A fourth substrate precursor is obtained on a glass slide of methylsiloxane; S15, the third substrate precursor is placed on a high-precision rotating platform, and the high-precision rotating platform is used to rotate the third substrate precursor at a torsion angle θ, and the fourth substrate precursor is attached to the third substrate precursor through the 3D rotating platform to obtain a fifth substrate precursor; S16, a plasma exposure machine is used to etch the fifth substrate precursor to remove the polymethyl methacrylate in the fifth substrate, and then a chromium metal layer and a gold metal layer are sequentially evaporated on the fifth substrate precursor using an evaporator to obtain a substrate.

[0012] Preferably, the torsion angle θ satisfies 5°≤θ<30°.

[0013] Preferably, the method for preparing the DNA origami structure comprises the steps of: adding a solution containing eight single-stranded DNAs of nucleic acid sequences such as SEQ ID No. 1-8 to a Tris-EDTA buffer solution, mixing, denaturing and renaturing, and forming a DNA origami structure having a tetrahedral structure.

[0014] Preferably, the temperature of the denaturation treatment is 95°C, and the temperature of the renaturation treatment is 0-4°C.

[0015] Preferably, the specific steps of combining the DNA origami structure and the CRISPR recognition unit with the substrate include: S41, rinsing the substrate with TM buffer and blowing dry with nitrogen; S42, dropping the DNA origami structure on the substrate, and then rinsing the substrate with TM buffer; S43, dropping the CRISPR recognition unit on the product of S42, coating 6-mercapto-1-hexanol, and then dropping a gold nanoparticle solution, and finally rinsing with TM buffer and blowing dry with nitrogen to obtain a biosensor.

[0016] The third aspect of the present application provides a use of the biosensor of the first aspect of the present application in the preparation of a gene diagnosis product.

[0017] Compared with the prior art, this application has the following advantages:

[0018] (1) The present application uses double-layer twisted graphene (tBLG) to accurately match the absorption characteristics of the Van Hove singularity (VHS) in the tBLG with the resonance peak of the heterojunction structure between the gold nanoarray layers located on the surface of the tBLG, thereby significantly enhancing the photocurrent of the biosensor and achieving signal amplification.

[0019] (2) The DNA folding structure is combined with the gold nanoparticles (AuNPs) in the gold nanoarray layer, so that the DNA folding structure is adsorbed on the surface of the gold nanoarray layer to maintain the precise distance between each AuNPs in the gold nanoarray layer. The presence of AuNPs can significantly change the resonance peak position of the heterojunction structure of the gold nanoarray, disrupt its coupling mode with tBLG, and lead to a reduction in the photocurrent signal; the CRISPR recognition unit ensures the single-base recognition ability of the biosensor, and then cuts the DNA origami structure through the cutting ability of the CRIPSR recognition unit to release the encapsulated AuNPs. As the external dielectric environment recovers, the coupling mode is regenerated. That is, by controlling the coupling mode formed between the heterojunction structure of tBLG and the gold nanoarray layer, the photocurrent of the biosensor is changed, and the response to different DNA sequences is differentiated, and the detection is completed. Combined with the precise manipulation of the DNA origami structure (DNA origami) at the nanoscale, the detection of the biosensor in the attomole range is achieved.

[0020] (3) The biosensor of the present application can identify low-abundance nucleic acid targets in complex biological samples by combining tBLG, gold nanoarrays, CRISPR recognition units, and DNA origami structures, and achieve highly specific detection of SNPs in ultra-low concentration samples. The biosensor of the present application provides a new paradigm for light-matter interaction and DNA detection in the two-dimensional limit, laying the foundation for the development of high-sensitivity molecular detection and nonlinear electro-optical modulation. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the technical solutions in the embodiments of the present application, the drawings required for describing the embodiments are briefly introduced below.

[0022] Figure 1 A schematic diagram of the structure of the biosensor provided in the embodiment of the present application;

[0023] Figure 2 A schematic diagram of a process for preparing a substrate provided in an embodiment of the present application;

[0024] Figure 3 This is a sensitivity detection diagram of the biosensor provided in an embodiment of the present application. DETAILED DESCRIPTION

[0025] In order to make the purpose, technical solutions and advantages of the present application clearer, the technical solutions in the embodiments of the present application will be clearly and completely described below in combination with the drawings and embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all the embodiments. Based on the embodiments of the present application, all other embodiments obtained by ordinary technicians in this field without making creative work belong to the protection scope of the present application. In the absence of conflict, the following embodiments and features in the embodiments can be combined with each other.

[0026] It should be noted that if there are descriptions involving "first", "second", etc. in the implementation of this application, the descriptions of "first", "second", etc. are only used for descriptive purposes and cannot be understood as indicating or suggesting their relative importance and implicitly indicating the number of technical features indicated. Therefore, the features defined as "first" and "second" may explicitly or implicitly include at least one of the features. In addition, the technical solutions between the various embodiments can be combined with each other, but they must be based on the fact that ordinary technicians in the field can implement them. When the combination of technical solutions is contradictory or cannot be implemented, it should be deemed that such combination of technical solutions does not exist and is not within the scope of protection required by this application.

[0027] Over the past few years, cancer deaths have grown to such an extent that it is considered the leading cause of death worldwide with nearly 10 million deaths recorded at the end of 2020. The success of cancer treatment depends largely on the stage at which it is discovered, so early diagnosis is crucial for effective treatment.

[0028] ctDNA refers to the somatic DNA of tumor cells that is released into the circulation system after shedding or apoptosis. It is a characteristic tumor biomarker. Through ctDNA detection, tumor traces in the blood can be detected. ctDNA is a cell-free extracellular DNA that exists in body fluids such as blood, synovial fluid and cerebrospinal fluid. It is mainly composed of single-stranded or double-stranded DNA and a mixture of single-stranded or double-stranded DNA, and exists in the form of DNA protein complex or free DNA. It is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors. Compared with protein markers, since ctDNA comes from tumor cell genome mutations, its detection rarely has false positives. In addition, ctDNA has a short half-life and can accurately reflect the current situation of the tumor. Single nucleotide polymorphisms (SNPs) refer to DNA sequence polymorphisms caused by variations in single nucleotides at the genomic level. Disease diagnosis, customized treatment and precision medicine require the ability to clarify gene mutations and variations at the molecular and single base levels. Therefore, detecting SNPs in ctDNA is an ideal detection method.

[0029] The main methods for detecting single nucleotide polymorphisms (SNPs) in ctDNA are polymerase chain reaction (PCR)-based detection methods, including next-generation sequencing (NGS), droplet digital PCR (ddPCR), and amplification of intractable mutation systems (ARMS). However, these methods have long processing times and cannot identify all SNPs. With the increasing attention paid to ctDNA, other detection technologies have also been developed, including isothermal amplification, microfluidics, and biosensors. Combined with surface plasmon resonance (SPR) biosensors, they have the advantages of label-free properties, fast real-time response, and high-throughput testing. However, current SPR biosensors still have many challenges, making it difficult to achieve high-specificity detection of SNPs in ultra-low concentration samples.

[0030] On the other hand, graphene has attracted extensive attention due to its outstanding characteristics such as electrochemical, adsorption properties, mechanical strength and flexibility, and has become a candidate material for biosensors. Twisted double-layer graphene (tBLG) leads to enhanced light absorption and Raman resonance. The light-matter interaction in two-dimensional materials is enhanced by integration with optical nanoantennas, and the detection sensitivity of sensors can be effectively improved by rationally constructing tBLG / nanoantenna structures. However, graphene-based biosensors also face many problems, such as the need to enhance the signal-to-noise ratio (SNR) to identify low-abundance nucleic acid targets in complex biological samples. CRISPR-Cas technology is a revolutionary gene editing technology that can distinguish nucleic acid sequences at the single-base level, and subsequent trans-cleavage can be used in a variety of genetic detection methods. However, conventional single-stranded DNA (ssDNA) probes immobilized on the chip surface hinder probe-target interactions due to two major problems: entanglement between adjacent probes (uncontrolled distance between gold particles) and entanglement between probes located on the surface (uncontrolled distance between gold particles and the surface), both of which lead to invalid probes occupying the chip surface. It can be seen that existing biosensors still have many problems and it is difficult to achieve high-specificity detection of SNPs in ultra-low concentration samples.

[0031] Based on this, a first aspect of an embodiment of the present application provides a biosensor, comprising:

[0032] A substrate and a DNA origami structure and a CRISPR recognition unit adsorbed on the substrate. The substrate includes a double-layer corner graphene layer and a gold nanoarray layer stacked. The DNA origami structure is a tetrahedral structure constructed by eight single-stranded DNAs, and the sequences of the eight single-stranded DNAs are shown in SEQ ID No. 1-8. The CRISPR recognition unit is configured to specifically bind to a specific nucleic acid sequence to achieve a recognition function.

[0033] In some embodiments, the 5' end of SEQ ID No. 1, SEQ ID No. 3, and SEQ ID No. 5 is also connected to a globular group -SH-C6-, and the addition of the globular group can make the DNA origami structure better adsorbed to the gold nanoparticles in the gold nanoarray.

[0034] In some embodiments, the twist angle θ of the double-layer twisted graphene metal layer in the double-layer twisted graphene structure substrate satisfies 5°≤θ<30°. For example, the twist angle θ is 5°, 7°, 9°, 9.4°, 10°, 13.2°, 15°, 20°, 22°, 25°, 26°, 27°, 28°29° or 29.9°, etc., which is less than 30°.

[0035] In some embodiments, the substrate includes a substrate layer, the substrate layer includes a silicon dioxide layer and a silicon layer stacked in sequence, and the silicon dioxide layer is located on a side of the double-layer corner graphene layer away from the gold nanoarray layer.

[0036] The CRISPR recognition unit includes a CRISPR-A sequence and a crRNA sequence. The CRISPR-A sequence and the DNA origami structure are mutually adsorbed, and the crRNA is used to specifically collect the nucleic acid to be tested. In some embodiments, the CRISPR-A sequence is shown in SEQ ID No. 9, and the crRNA sequence is shown in SEQ ID No. 10. It is used to recognize T-DNA obtained by reverse transcription of miRNA21.

[0037] Furthermore, the working principle of the biosensor is as follows Figure 1 As shown, the Dirac cones of individual monolayers in twisted bilayer graphene (tBLG) intersect to form saddle points, leading to the formation of van Hove singularities (VHS) in the density of states (DOS), which enhances light absorption and Raman resonance. The creation of high localized density of states (LDOS) near the interface of nanostructures and two-dimensional materials is believed to induce coupled modes in light-matter interactions. Since the formation of coupled modes requires precise alignment of structural resonances with the band gap of the material, primers from external reactors may disrupt the mode, thereby serving as a new biosensing mechanism.

[0038] By using double-layer twisted graphene (tBLG), the absorption characteristics of the Van Hove singularity (VHS) in tBLG are precisely matched with the resonance peak of the heterojunction structure between the tBLG surface and the gold nanoarray layer, which significantly enhances the photocurrent of the biosensor and achieves signal amplification.

[0039] Furthermore, DNA origami technology involves the self-assembly synthesis of two-dimensional or three-dimensional structures, eliminating the persistent problems of entanglement and surface laying anomalies of traditional ssDNA probes and improving sensor sensitivity. Gold nanoparticles (AuNPs) with tetrahedral structures combined with DNA origami structures are fixed on the surface of gold nanodisks to maintain the precise distance between individual AuNPs in the gold nanodisk layer. The presence of AuNPs can significantly change the resonance peak position of the heterojunction structure of the gold nanodisk, disrupt its coupling mode with tBLG, and lead to a reduction in the photocurrent signal; the CRISPR recognition unit ensures the single-base recognition ability of the biosensor, and then the DNA folding structure is sheared and released through the cutting ability of the CRISPR recognition unit to release the encapsulated AuNPs. As the external dielectric environment recovers, the coupling mode is regenerated. That is, by controlling the coupling mode formed between the heterojunction structure of tBLG and the gold nanodisk layer, the photocurrent of the biosensor is changed, the response to different DNA sequences is achieved, and the detection is completed. By combining the precise manipulation of the nanoscale of the DNA origami structure and the ultrathin structure of tBLG, the biosensor can detect in the attomole range.

[0040] The biosensor of the first aspect of the embodiment of the present application can identify low-abundance nucleic acid targets in complex biological samples and achieve high-specificity detection of SNPs in ultra-low concentration samples by combining tBLG, gold nanoarray, CRISPR recognition unit and DNA origami structure.

[0041] According to a second aspect of the embodiment of the present application, there is provided a method for preparing the biosensor according to the first aspect of the embodiment of the present application, comprising the steps of:

[0042] S1, preparing a substrate;

[0043] S2, preparation of DNA origami structures;

[0044] S3, preparing CRISPR recognition unit;

[0045] S4. Combine the DNA origami structure and the CRISPR recognition unit with a substrate to produce a biosensor.

[0046] In some embodiments, see Figure 2 , the preparation method of the substrate comprises the steps of:

[0047] S11. Spin-coat polymethyl methacrylate (PMMA) on a graphene single crystal grown by chemical vapor deposition on a copper foil to obtain a first substrate precursor.

[0048] S12, using a femtosecond laser to cut the first substrate precursor, and using an etching solution to etch the copper foil therein, to obtain a second substrate precursor with parallel crystal phases.

[0049] S13, transferring the second substrate precursor to the center of the silicon dioxide / silicon substrate layer, and removing the PMMA layer using an acetone solution to obtain a third substrate precursor.

[0050] S14, transferring the second substrate precursor to a glass slide attached with polydimethylsiloxane (PDMS) to obtain a fourth substrate precursor.

[0051] S15, placing the third substrate precursor on a high-precision rotating platform, rotating it at a torsion angle θ through the high-precision rotating platform, and then attaching the fourth substrate precursor to the third substrate precursor through the 3D rotating platform to obtain a fifth substrate precursor.

[0052] S16, using a plasma exposure machine (EBL) to perform an etching process on the fifth substrate precursor to remove the PMMA in the fifth substrate, and then using an evaporator to sequentially evaporate a chromium metal layer and a gold metal layer on the fifth substrate precursor to obtain a substrate.

[0053] In some embodiments, the specific steps of spin coating in S11 are: first spin coating PMMA at 750 rpm for 10 s, then spin coating PMMA at 2000 rpm for 60 s, and then heating at 100° C. for 60 s.

[0054] In some embodiments, the etching solution includes hydrochloric acid, hydrogen peroxide and water, and the volume ratio of hydrochloric acid, hydrogen peroxide and water is 1:1:8.

[0055] In some embodiments, the torsion angle θ in S14 satisfies 5°≤θ<30°. For example, the torsion angle is 5°, 7°, 9°, 9.4°, 10°, 13.2°, 15°, 20°, 22°, 25°, 26°, 27°, 28°29° or 29.9°, etc., which is less than 30°.

[0056] In some embodiments, the thickness of the evaporated chromium metal layer is 5 nm, and the thickness of the evaporated gold metal layer is 45 nm.

[0057] In some embodiments, the method for preparing a DNA origami structure comprises the steps of:

[0058] S21. Add eight nucleotide sequences (sequences shown in SEQ ID No. 1-8) for constructing a DNA origami structure into a Tris-EDTA (TE) buffer solution, mix, and perform denaturation and renaturation treatment to form a DNA origami structure with a tetrahedral structure.

[0059] In some embodiments, the denaturation temperature is 95° C., the denaturation time is 10 min, and the renaturation temperature is 0-4° C. For example, the renaturation can be performed directly on ice.

[0060] In some embodiments, the method for preparing a CRISPR recognition unit comprises the steps of:

[0061] S31. Prepare the CRISPR-A sequence into a solution to obtain a CRISPR recognition unit.

[0062] In some embodiments, the specific steps of S4 include:

[0063] S41, washing the substrate with TM buffer and blowing it dry with nitrogen gas;

[0064] S42, drop the DNA origami structure onto the substrate, and wash with TM buffer for 5 min after 30 min;

[0065] S43, drip the CRISPR recognition unit onto the product of S42, apply 6-mercapto-1-hexanol after 30 minutes, drip the gold nanoparticle solution after 15 minutes, wait for 30 minutes, rinse with TM buffer and blow dry with nitrogen to make a biosensor. Among them, TM buffer includes Tris-HCl and MgSO4. 6-Mercapto-1-hexanol (MCH) can seal the surface of the gold nanoarray to prevent the gold nanoarray from being adsorbed with other substances in subsequent preparation or reaction. The dripped gold nanoparticle solution combines with the PloyA structure on the top of the DNA origami structure, and the light field localization effect of the gold nanostructure is destroyed.

[0066] After matching the absorption peak of the corner graphene with the plasmon resonance peak, a light source matching the absorption peak is selected to shine on the sensor, and the DNA chain that can be cut by the Cas12a protein is combined with the DNA origami connected to the surface of the nanoarray, and the other end is connected to gold nanoparticles (AuNPs). Due to the change of the external environment caused by AuNPs, the resonance peak of the gold nanoarray is offset, making the electromagnetic field of the nanoarray localized and the corner graphene mismatched, the photoelectric conversion rate is reduced, and the photocurrent is reduced. When the target DNA is identified to enter, under the guidance of crRNA, the Cas12a protein cuts the DNA chain, causing AuNPs to detach from the sensor surface, resulting in a significant change in the near-field electromagnetic field intensity near it, and the photocurrent value has a huge fluctuation. By calculating the change in the current value before and after shearing, the target virus is identified and quantitatively analyzed, and the sensor is then able to identify the target DNA.

[0067] The third aspect of the present application provides an application of the biosensor of the first aspect of the present application in the preparation of a gene diagnosis product, wherein the diagnosis product can be used to diagnose whether a patient has a certain cancer or carries a certain virus.

[0068] In some embodiments, when a diagnostic product is used to detect whether a patient has a certain cancer, it is only necessary to sample the patient's blood, and the miRNA in the sampled blood is made into T-DNA by reverse transcription, and crRNA is designed according to the marker of the cancer to be detected, and T-DNA, Cas12a protein reaction solution (Cas12a protein reaction solution is purchased and obtained, and suitable reaction conditions can be provided for Cas12a protein), Cas12 protein and crRNA are mixed, dripped into the sensor, and the sensor is placed in a flow cell for CRISPR reaction incubation at 37°C for 30min, and then the sensor is rinsed with TM buffer, and proteinase K is added dropwise for 10min to remove non-specific adsorption, and then rinsed with TM buffer. The photocurrent change of the sensor before and after the sample is added can be used to judge specific cancers.

[0069] In some embodiments, the amount of Cas12a protein added is 20 μL, the amount of protein reaction solution added is 20 μL, the amount of crRNA added is 10 μL, the amount of T-DNA added is 10 μL, the total volume of the detection solution system is 200 μL, and ultrapure water is used to make up the volume.

[0070] In some embodiments, when using diagnostic products to detect whether a patient has a certain cancer, it is only necessary to sample the patient's blood, design crRNA according to the marker of the virus to be detected, mix the sampled blood, Cas12a protein reaction solution, Cas12 protein and crRNA, drip into the sensor, and place the sensor in a flow cell for CRISPR reaction incubation at 37°C for 30 minutes, then rinse the sensor with TM buffer, and drip proteinase K for 10 minutes to remove non-specific adsorption, and then rinse with TM buffer. Detecting the change in the photocurrent of the sensor before and after the sample is added can determine specific cancers.

[0071] In some embodiments, the amount of Cas12a protein added is 20 μL, the amount of protein reaction solution added is 20 μL, the amount of crRNA added is 10 μL, the amount of sampled blood added is 10 μL, the total volume of the detection liquid system is 200 μL, and ultrapure water is used to make up the volume.

[0072] The following is further described by means of specific examples.

[0073] Example 1 Preparation of biosensor

[0074] The specific preparation method comprises the following steps:

[0075] (1) Polymethyl methacrylate (PMMA) was spin-coated on a graphene single crystal grown by chemical vapor deposition on a copper foil (Copper foil / Gr), first at 750 rpm for 10 s, then at 2000 rpm for 60 s, and then heated at 100°C for 60 s to obtain PMMA / graphene / copper foil (Copper foil / Gr / PMMA). The PMMA / graphene / copper foil in (1) was cut using a femtosecond laser with a wavelength of 800 nm. The copper foil was etched using an etching solution with a volume ratio of HCl:H2O2:H2O of 1:1:8 to obtain two PMMA / graphene (PMMA / Gr) sheets with parallel crystals. One of the PMMA / graphene sheets was transferred to the center of the silicon dioxide / silicon substrate layer to obtain Si / SiO2 / Gr / PMMA, and the PMMA coating was removed using an acetone solution to obtain Si / SiO2 / Gr. Si / SiO2 / Gr was placed on a high-precision rotating platform as the bottom layer of tBLG, and then another piece of PMMA / Gr was transferred to a glass slide attached with polydimethylsiloxane (PDMS) to obtain glass slide / PDSM / PMMA / graphene (Glass / PDMS / PMMA / Gr). The bottom graphene was rotated 9.4° on the silicon dioxide / silicon substrate layer by a rotating platform, and the top graphene was adhered to the bottom graphene by a 3D translation platform (E1-G, Meta) to obtain Si / SiO2 / tBLG / PMMA / Glass. After soaking in a pure acetone solution for 30 minutes, the residual PMMA was removed by thermal annealing at 340°C under vacuum conditions for 3 hours to obtain Si / SiO2 / tBLG. PMMA was spin-coated on Si / SiO2 / tBLG at 750rpm for 10s, then at 4000rpm for 60s, and then heated at 100℃ for 60s to obtain Si / SiO2 / tBLG / PMMA. PMMA was etched using an EBL, and the exposed PMMA was removed after development and fixation. 5nm chromium and 45nm gold were evaporated using a coating instrument, and then excess metal was removed using acetone to obtain Si / SiO2 / tBLG / Au-nanodisk.

[0076] (2) Eight solutions containing single-stranded DNA (sequences as shown in SEQ ID No. 1-8, wherein the 5' end of the 1st, 3rd and 5th single-stranded DNA includes globin-SH-C6-) were centrifuged at 7000×g for 5 min at 4°C, then diluted to 100 μM with Tris-EDTA (TE) buffer and stored at -20 to -80°C. 2 μL of each prepared solution was mixed with 184 μL of Tris-magnesium sulfate (TM) buffer to make the final concentration of each single-stranded DNA 1 μM. The prepared solution was heated to 95°C for 10 min, then quickly cooled on ice to obtain a DNA origami structure for later use.

[0077] (3) The Si / SiO2 / tBLG / Au-nanodisk prepared in (1) was rinsed with TM buffer and dried with nitrogen, and the DNA origami structure in (2) was incubated for 30 minutes, and then rinsed with TM buffer for 5 minutes. Then, a solution containing CRISPR-A (sequence shown in SEQ ID No. 9) was added dropwise and incubated for 30 minutes, and then 6-mercapto-1-hexanol was added dropwise for MCH blocking treatment for 15 minutes, and finally, a gold nanoparticle (Au-NP) solution was added and incubated for 30 minutes.

[0078] (4) The product in (3) was rinsed and dried with nitrogen gas to obtain a biosensor having the structure of Si / SiO2 / tBLG / Au-nanodisk / DNA origami / AuNP.

[0079] Example 2 Biosensor Sensitivity Detection

[0080] In order to characterize the sensitivity of the biosensor, the photocurrent values ​​generated before and after different concentrations (100 pmol-10 amol) of target DNA (T-DNA, sequence as shown in SEQ No ID.11) were added to the biosensor prepared in Example 1 were measured under optimal conditions.

[0081] The electrical measurements were performed using a phase-locked amplifier CIQTEK Melab instrument, and the photoelectric measurements were performed using a scanning photocurrent microscope. A laser source with adjustable output frequency at wavelengths of 405nm, 532nm, 660nm, and 785nm was used, and the output frequency of the light source was set to 1kHz. The light spot of 1μm was focused on the device through a ×100 objective lens, and the device was connected to a preamplifier and a voltage source ITECH IT2805 to provide bias voltage, and the photocurrent was measured through a phase-locked amplifier. While scanning the laser spot on the device, the induced photocurrent and the beam position were recorded simultaneously and displayed with the help of a computer for photocurrent testing. All electrical and photoelectric measurements were performed under room temperature environmental conditions.

[0082] T-DNA (sequence as shown in SEQ ID No.11) was generated by reverse transcription from miRNA-21, and the crRNA sequence is shown in SEQ ID No.10. The crRNA / T-DNA mixture was dripped onto the biosensor and incubated for CRISPR reaction at 37°C. Subsequently, the signal threshold was evaluated using a synthetic target DNA template. The threshold was calculated following the guidelines of the International Union of Pure and Applied Chemistry and included the sum of blank measurements and three times their standard deviation. The test results are shown in Figure 3 As shown, from Figure 3 It can be seen that the LOD value is significantly reduced, which may be attributed to the high sensitivity of the coupling mode of Au-nanodisk structural resonance and tBLG material band gap alignment to the external environment, as well as the highly versatile control of DNA origami on 3D spatial structure. This further illustrates that the biosensor prepared in Example 1 can achieve high specificity detection of ultra-low concentration (less than 1fM) target SNPs. Compared with traditional CRISPR detection technology, such as CRISPR-SHERLOCK, its detection limit is enhanced by more than 4 orders of magnitude.

[0083] In summary, the biosensor of the present application can identify low-abundance nucleic acid targets in complex biological samples by combining tBLG, gold nanoarrays, CRISPR recognition units and DNA origami structures, and achieve high-specificity detection of SNPs in ultra-low concentration samples. The sensor of the present application provides a new paradigm for light-matter interaction and DNA detection in the two-dimensional limit, laying the foundation for the development of high-sensitivity molecular detection and nonlinear electro-optical modulation.

[0084] It should be understood that the application of the present application is not limited to the above examples. For ordinary technicians in this field, improvements or changes can be made based on the above description. All these improvements and changes should fall within the scope of protection of the claims attached to this application.

Claims

1. A biosensor, characterized in that: The biosensor comprises: A substrate comprising a stacked double-layer corner graphene layer and a gold nanoarray layer; a DNA origami structure adsorbed on the gold nanoarray layer; A CRISPR recognition unit adsorbed on the DNA origami structure; Wherein, the DNA origami structure is a tetrahedral structure constructed by DNA origami technology using 8 DNA single strands represented by nucleic acid sequences such as SEQ ID No.1-8; The CRIPSR recognition unit specifically binds to the nucleic acid sequence to be detected.

2. The biosensor according to claim 1, characterized in that The twist angle θ of the two graphene layers in the double-layer twisted graphene layer satisfies 5°≤θ<30°.

3. The biosensor according to claim 1, characterized in that The substrate further comprises a substrate layer, which comprises a silicon dioxide layer and a silicon layer stacked in sequence, and the silicon dioxide layer is located on a side of the double-layer corner graphene layer away from the gold nano-array layer.

4. A method for preparing a biosensor according to any one of claims 1 to 3, characterized in that: Includes steps: S1. preparing a substrate; S2, preparation of DNA origami structures; S3, preparing CRISPR recognition unit; S4. Combine the DNA origami structure and the CRISPR recognition unit with a substrate to produce a biosensor.

5. The preparation method according to claim 4, characterized in that: The method for preparing the substrate comprises the steps of: S11, spin coating polymethyl methacrylate on graphene grown by chemical vapor deposition on copper foil to obtain a first substrate precursor; S12, cutting the first substrate precursor using a femtosecond laser, and etching the copper foil therein using an etching solution to obtain a second substrate precursor with parallel crystal phases; S13, transferring the second substrate precursor to the center of the substrate layer, and removing the polymethyl methacrylate using an acetone solution to obtain a third substrate precursor; S14, transferring the second substrate precursor to a glass slide with polydimethylsiloxane attached thereto to obtain a fourth substrate precursor; S15, placing the third substrate precursor on a high-precision rotating platform, rotating the high-precision rotating platform at a torsion angle θ, and attaching the fourth substrate precursor to the third substrate precursor through the 3D rotating platform to obtain a fifth substrate precursor; S16, using a plasma exposure machine to perform etching treatment on the fifth substrate precursor to remove the polymethyl methacrylate in the fifth substrate, and then using an evaporator to sequentially evaporate a chromium metal layer and a gold metal layer on the fifth substrate precursor to obtain a substrate.

6. The preparation method according to claim 5, characterized in that: The torsion angle θ satisfies 5°≤θ<30°.

7. The preparation method according to claim 4, characterized in that: The preparation method of the DNA origami structure comprises the steps of: A solution containing eight single-stranded DNAs with nucleic acid sequences such as SEQ ID No. 1-8 is added to a Tris-EDTA buffer solution and mixed, and subjected to denaturation and renaturation treatment to form a DNA origami structure with a tetrahedral structure.

8. The preparation method according to claim 7, characterized in that: The temperature of the denaturation treatment is 95°C, and the temperature of the renaturation treatment is 0-4°C.

9. The preparation method according to claim 4, characterized in that: The specific steps of combining the DNA origami structure and the CRISPR recognition unit with the substrate include: S41, washing the substrate with TM buffer and blowing it dry with nitrogen gas; S42, dropping the DNA origami structure onto the substrate, and then washing the substrate with TM buffer; S43. Add the CRISPR recognition unit onto the product of S42, coat with 6-mercapto-1-hexanol, then add the gold nanoparticle solution, and finally rinse with TM buffer and blow dry with nitrogen to prepare the biosensor.

10. Use of the biosensor according to any one of claims 1 to 3 in the preparation of gene diagnosis products.

Citation Information

Patent Citations

  • Plasmon resonance enhanced substrate and preparation method and application thereof

    CN112986171A

  • Nucleic acid analysis method and application

    CN113774114A

  • Biosensor constructed by combining nucleic acid chip and photoelectrochemistry

    CN115684299A

  • Application of gold nanoparticle combined graphene metamaterial chip in preparation of kit for detecting ctDNA, method and product

    CN116218959A

  • Resist underlayer composition, and method of forming patterns using the composition

    KR102745439B1

Cited By

  • Ultra-sensitive biosensor as well as preparation method and application thereof

    CN120210332A

  • An ultrasensitive biosensor, its preparation method and application

    CN120210332B

  • CRISPR-Cas system and MetaSPR optical sensor combined quantitative detection system, detection method and application

    CN121141595A

  • Physical unclonable anti-counterfeiting material based on DNA (Deoxyribose Nucleic Acid) nanostructure as well as preparation method and application thereof

    CN121950294A